| Q37547272 | A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix |
| Q40285318 | A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children |
| Q48502641 | A new justification for pediatric research without the potential for clinical benefit |
| Q37243993 | Acute gastroenteritis in a pediatric hospital in rio de janeiro in pre- and post-rotavirus vaccination settings |
| Q36904890 | Acute infectious pediatric gastroenteritis: beyond oral rehydration therapy |
| Q58892227 | Assessing the introduction of universal rotavirus vaccination in the Netherlands |
| Q90481177 | Association Between Rotavirus Vaccination and Risk of Intussusception Among Neonates and Infants: A Systematic Review and Meta-analysis |
| Q34290838 | Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine. |
| Q42201985 | Bovine rotavirus pentavalent vaccine development in India |
| Q37850759 | Burden and typing of rotavirus group A in Latin America and the Caribbean: systematic review and meta-analysis. |
| Q44799836 | Burden of disease and costs of treating rotavirus diarrhea in Mexican children for the period 2001-2006. |
| Q37175169 | Changing epidemiology of rotavirus-related hospitalizations in rio de janeiro, Brazil, from 2002 to 2006. |
| Q39991868 | Clinical Severity and Rotavirus Vaccination among Children Hospitalized for Acute Gastroenteritis in Belém, Northern Brazil |
| Q46232575 | Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines. |
| Q56793962 | Cost and cost-effectiveness of childhood vaccination against rotavirus in France |
| Q36111776 | Cost effectiveness of infant vaccination for rotavirus in Canada |
| Q41279252 | Cost-effectiveness analysis of rotavirus vaccination in Argentina |
| Q38445972 | Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran. |
| Q33401714 | Cost-effectiveness of Rotavirus vaccination in Vietnam |
| Q44938367 | Cost-effectiveness of childhood rotavirus vaccination in Taiwan |
| Q38859266 | Cost-effectiveness of rotavirus vaccination in Kenya and Uganda |
| Q40304552 | Detection and molecular characterization of group A rotavirus from hospitalized children in Rio de Janeiro, Brazil, 2004. |
| Q42259918 | Detection of rotavirus in children with acute gastroenteritis in Porto Velho, Rondonia, Brazil |
| Q37339643 | Economic impact of a rotavirus vaccine in Brazil |
| Q38903517 | Effect of monovalent rotavirus vaccine on rotavirus disease burden and circulating rotavirus strains among children in Morocco |
| Q79958029 | Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study |
| Q92615046 | Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials |
| Q95830341 | Efficacy, immunogenicity and safety of a trivalent live human-lamb reassortant rotavirus vaccine (LLR3) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial |
| Q36249319 | Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean. |
| Q64130682 | Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries? |
| Q35943681 | Factors influencing willingness to participate in new drug trial studies: a study among parents whose children were recruited into these trials in northern Ghana |
| Q84500544 | Gastroenteritis in children |
| Q84595951 | Gastroenteritis in children |
| Q54343219 | Genotyping of human rotaviruses circulating among children with diarrhea in Valencia, Venezuela. |
| Q39291307 | Heterogeneity and temporal dynamics of evolution of G1 human rotaviruses in a settled population |
| Q34789779 | Heterogeneity of rotavirus testing and admitting practices for gastroenteritis among 12 tertiary care pediatric hospitals: Implications for surveillance |
| Q37713426 | Human rotavirus strains circulating in Venezuela after vaccine introduction: predominance of G2P[4] and reemergence of G1P[8]. |
| Q44793215 | Identification of two sublineages of genotype G2 rotavirus among diarrheic children in Parauapebas, Southern Pará State, Brazil |
| Q37134934 | Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants |
| Q84384797 | Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe |
| Q47251751 | Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction |
| Q57029745 | Impfstoffe gegen Durchfallserkrankungen – am Beispiel der Impfstoffe gegen Reisediarrhoe und gegen Rotavirus |
| Q37308484 | Inactivated rotavirus vaccines: a priority for accelerated vaccine development |
| Q37264906 | Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination |
| Q34374858 | Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review. |
| Q36992562 | Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines |
| Q61804344 | Interventions to improve oral vaccine performance: a systematic review and meta-analysis |
| Q36918275 | Introduction of rotavirus vaccines in developing countries: remaining challenges. |
| Q90732424 | Kawasaki Disease and the Use of the Rotavirus Vaccine in Children: A Systematic Review and Meta-Analysis |
| Q35976778 | Knowledge and Perceptions about Clinical Trials and the Use of Biomedical Samples: Findings from a Qualitative Study in Rural Northern Ghana |
| Q64136984 | Longer-term Direct and Indirect Effects of Infant Rotavirus Vaccination Across All Ages in the United States in 2000-2013: Analysis of a Large Hospital Discharge Data Set |
| Q54094430 | Monitoring shedding of five genotypes of RotaTeq vaccine viruses by genotype-specific real-time RT-PCR assays. |
| Q37464683 | Mucosal immunology of geohelminth infections in humans |
| Q36993936 | Mutation distribution in the NSP4 protein in rotaviruses isolated from Mexican children with moderate to severe gastroenteritis |
| Q36871954 | Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial |
| Q24600612 | Performance of rotavirus vaccines in developed and developing countries |
| Q89723679 | Post-vaccination serum anti-rotavirus immunoglobulin A as a correlate of protection against rotavirus gastroenteritis across settings |
| Q51143331 | Potential epidemiological and economical impact of two rotavirus vaccines in Colombia. |
| Q35784989 | Predominance of rotavirus G1[P8] genotype among under-five children with gastroenteritis in Mwanza, Tanzania |
| Q37012078 | Prevention of childhood rotavirus disease through the use of Rotarix and RotaTeq vaccines |
| Q40122963 | Projecting vaccine efficacy: accounting for geographic strain variations. |
| Q34574852 | Rotarix (RIX4414): an oral human rotavirus vaccine |
| Q34900447 | Rotarix: a rotavirus vaccine for the world |
| Q47610785 | Rotarix® and RotaTeq® administration to preterm infants in the neonatal intensive care unit: Review of available evidence |
| Q42248692 | Rotavirus G and P types circulating in the eastern region of Kenya: predominance of G9 and emergence of G12 genotypes |
| Q43365960 | Rotavirus epidemiology and vaccine demand: considering Bangladesh chapter through the book of global disease burden. |
| Q37769212 | Rotavirus infections and vaccines: burden of illness and potential impact of vaccination |
| Q37694873 | Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine. |
| Q47323773 | Rotavirus vaccination can be performed without viral dissemination in the Neonatal Intensive Care Unit |
| Q79416539 | Rotavirus vaccine RIX4414 (Rotarix) |
| Q37363968 | Rotavirus vaccine RIX4414 (Rotarix): a review of its use in the prevention of rotavirus gastroenteritis |
| Q37944318 | Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries |
| Q40030087 | Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population |
| Q38801789 | Rotavirus vaccine strain transmission by vaccinated infants in the foster home |
| Q34550164 | Rotavirus vaccines: current prospects and future challenges |
| Q37081817 | Rotavirus vaccines: how they work or don't work |
| Q36850161 | Rotavirus vaccines: recent developments and future considerations. |
| Q37298870 | Rotavirus vaccines: viral shedding and risk of transmission |
| Q50211548 | Rotavirus-specific IgA Responses Are Impaired and Serve as a Sub-Optimal Correlate of Protection among Infants in Bangladesh |
| Q24609374 | Rotaviruses: from pathogenesis to vaccination |
| Q40477967 | Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. |
| Q37992392 | Safety reporting in developing country vaccine clinical trials-a systematic review |
| Q57936381 | Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age |
| Q40722641 | Sustained Reduction of Childhood Diarrhea-Related Mortality and Hospitalizations in Mexico After Rotavirus Vaccine Universalization |
| Q26770871 | The clinical development process for a novel preventive vaccine: An overview |
| Q44902395 | The cost-effectiveness of rotavirus vaccination in Australia |
| Q90678316 | The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial |
| Q38551946 | The health and economic burden of rotavirus disease in Belgium |
| Q37640107 | Update on Rotarix: an oral human rotavirus vaccine |
| Q34572829 | Vaccines against traveler's diarrhoea and rotavirus disease - a review. |
| Q24197495 | Vaccines for preventing rotavirus diarrhoea: vaccines in use |
| Q24203645 | Vaccines for preventing rotavirus diarrhoea: vaccines in use |
| Q24235411 | Vaccines for preventing rotavirus diarrhoea: vaccines in use |
| Q64117280 | Vaccines for preventing rotavirus diarrhoea: vaccines in use |
| Q37318562 | Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany? |